However, there was no significant difference between relapse‐free survival (RFS) in patients with HNSCC with high expression levels of HPRT1 mRNA compared with those with low expression levels (P = 0.22; Fig. 4B). This evidence concerns the gene HPRT1 and head and neck squamous cell carcinoma.